Chinese medicinal composition for treating chronic obstructive pulmonary disease
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A chronic obstructive, composition technology, applied in the directions of drug combination, pharmaceutical formula, plant raw material, etc., can solve the problems of low cure rate, difficult treatment, high disability rate, and achieve increased phenol red excretion, asthma and phlegm relief. Signs, the effect of improving signs
Active Publication Date: 2012-07-11
李友林
View PDF0 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0002] Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by airflow limitation, which is not fully reversible and develops progressively, and is harmful to the lungs such as cigarette smoke. It is related to the abnormal inflammatory response of gas or harmful particles. It is a common and frequently-occurring disease in the respiratory system among complex diseases. It has high morbidity, high mortality, high disability rate, high recurrence rate, and many complications. The characteristics of low cure rate; COPD mainly involves the lungs, but can also cause systemic (or extrapulmonary) adverse effects, seriously affecting the patient's working ability and quality of life, difficult treatment, significantly shortened life expectancy, and is a threat to public physical and mental health. one of the major diseases;
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0319] Embodiment 1: water decoction
[0320] Raw Astragalus 15g Schisandra 6g Epimedium 4.5g
[0322] Take the above-mentioned crude drug, add water to decoct twice, the amount of water added is the usual amount, and the water extract is combined to make a water decoction.
Embodiment 2
[0323] Embodiment 2: dropping pill
[0324] Raw Astragalus 15g Schisandra 6g Epimedium 4.5g
[0326] Take the above-mentioned crude drug, add water to extract twice, each time for 1 hour, combine the filtrate, concentrate and dry, add the drug loading amount of 30% to the matrix (PEG4000:PEG6000=8:1), mix well, and control the condensation temperature at 2°C-6°C; Dropping conditions are: dropping temperature 70-75°C, drop distance 4cm, cooling column length 75cm; make drop pills.
Embodiment 3
[0327] Embodiment 3: pill
[0328] Raw Astragalus 20g Schisandra 4g Epimedium 3.5g
[0329] Fangfeng 8g Honey Roasted Inula (fried) 6g
[0330] Take the above crude drug, add water to extract 3 times, each time for 1 hour, combine the filtrate, concentrate and dry, add conventional auxiliary materials, and make pills according to the conventional process.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a Chinese medicinal composition for treating a chronic obstructive pulmonary disease in a stable period. The Chinese medicinal composition consists of five bulk pharmaceuticals including crude astragalus, Chinese magnoliavine fruit, epimedium herb, divaricate saposhnikovia root and honey-fried inula flower (decocted in a packet). As proved by pharmaceutical effect experiments, the Chinese medicinal composition has remarkable asthma-preventing, phlegm-eliminating and cough-relieving effects, and has certain suppressing effects on rat and mouse exudative inflammations; and as proved by in-vitro experiments, the Chinese medicinal composition has certain bacteriostasis effects on common respiratory tract pathogens, and has remarkable protecting effects on mice infected with staphylococcus aureus and pneumococcus. Meanwhile, as proved by clinical test researches, the Chinese medicinal composition has remarkable advantages on the aspects of asthma prevention, phlegm elimination and sign improvement.
Description
technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for chronic obstructive pulmonary disease. Background technique [0002] Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by airflow limitation, which is not fully reversible and develops progressively, and is harmful to the lungs such as cigarette smoke. It is related to the abnormal inflammatory response of gas or harmful particles. It is a common and frequently-occurring disease in the respiratory system among complex diseases. It has high morbidity, high mortality, high disability rate, high recurrence rate, and many complications. The characteristics of low cure rate; COPD mainly involves the lungs, but can also cause systemic (or extrapulmonary) adverse effects, seriously affecting the patient's working ability and quality of life, difficult treatment, significantly short...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more